genentech

Welcome to the 'genentech' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'genentech'.

Latest blogosphere posts tagged “genentech”

• Another View: Innovation Can Unlock Job Growth

  
  DealBook — Authority: 760
  Another View: Bill George, a Harvard business professor and the author of "7 Lessons for Leading in Crisis," puts forth some proposals to revive employment growth in a declining job market.
  3 days ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 587
  Welcome to the working week. Hope your long weekend - those of you who are stateside, at least - was a good one. Ours was quiet, thanks. So, no complaints. Now, though, the routine returns. And that means deadlines, projects and meetings. To help you along, here are a few interesting items to help you ease back in. So ...
  4 days ago

• Ironwood Pharma Eyes $172.5M IPO, Biogen CEO Pay Under Fire, & More Boston Life Sciences News

  
  Xconomy — Authority: 670
  Life Sciences , deals , Multiple Sclerosis Ryan McBride wrote: Xconomy’s life sciences coverage this past week featured a mix of exclusive feature stories—such as Luke’s analysis of the PML side effect from Biogen Idec’s natalizumab (Tysabri)—and breaking news stories like Ironwood ...
  1 week ago

• CMS Moves Up Avastin Pricing Changes

  
  Pharmalot — Authority: 587
  After pressure from Congress, the Centers for Medicare and Medicaid has accelerated its recently announced changes to reimbursement coding for Avastin, which is used to treat wet macular degeneration, a leading cause of blindness among seniors. The drug, however, is controversial because it’s often used off-label in ...
  1 week ago

• ImmunoGen Signs 2nd Licensing Deal with Amgen

  
  OneMedPlace — Authority: 465
  ImmunoGen has licensed its anti-cancer technology to Amgen for an upfront payment of $1 million. The deal gives biotechnology company Amgen the right to use ImmunoGen’s maytansinoid targeted antibody payload (TAP) technology to create cancer-fighting therapies to an undisclosed target. In addition to the ...
  1 week ago

• Big Pharma Lobbyists Script Speeches In U.S. Congress, Industry Fights Against Generic Drugs

  
  DeSmogBlog - Clearing the PR Pollution that Clouds Climate Science — Authority: 638
  pharma_pills.jpg While our focus here at DeSmogBlog is to expose the public relations and lobbying antics that hinder effective responses to climate change, we are always on the lookout for other examples of how lobbying and PR impede progress on critical legislative efforts to protect people ...
  1 week ago

• Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M

  
  Xconomy — Authority: 670
  Biotech , deals , startups Luke Timmerman wrote: Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for bowel disorders like for irritable bowel syndrome and chronic constipation said it may raise as much as $172.5 million from ...
  2 weeks ago

• Hot Topics at HBA

  
  PharmExec Blog — Authority: 418
  The 2009 Healthcare Businesswomen’s Association leadership conference is officially underway in sunny California. Last night, festivities got underway with a welcome reception for attendees followed by a “Taste of San Francisco,” which featured lively entertainment and regional cuisine. I had the opportunity to ...
  2 weeks ago

• The Lobbyists Ability To Control The Message

  
  Computer & Internet - computer-internet.marc8.com — Authority: 169
  It certainly wont come as much of a surprise to readers around here that lobbyists from Roche/Genentech were able to get 42 different members of Congress to include text they had written into the Congressional Record. read more
  2 weeks ago

• Parties for the Parrots!!

  
  Emptywheel — Authority: 715
  Remember those Republicans and Democrats who took Roche/Genentech’s script and inserted it, barely touched, into the Congressional Record? It will surprise none of you that there were parties involved . Rep. Bill Pascrell (D-NJ) was scheduled to attend a breakfast fundraiser at the Phoenix Park Hotel on ...
  2 weeks ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 587
  Good morning, everyone. Nice to see you again. Another pleasant day looks to be shaping up on the Pharmalot corporate campus. But so much to do and we know you can relate. So while we shuttle to and from the schoolhouse, here are a few items to help you on your own way…. Roche Applies for Avastin Breast Cancer Use ...
  2 weeks ago

• Lobbyists Put On Ventriloquist Act

  
  Sunlight Foundation — Authority: 622
  More than a dozen lawmakers inserted statements supporting a biotechnology provision added to the House health care bill that was crafted by lobbyists for the biotechnology firm Genentech. According to the New York Times , “lobbyists, employed by Genentech and by two Washington law firms, were remarkably successful ...
  2 weeks ago

• No sense even pretending anymore

  
  dustbury.com — Authority: 584
  Who said this? “One of the reasons I have long supported the U.S. biotechnology industry is that it is a homegrown success story that has been an engine of job creation in this country.” Was it: Rep. Blaine Luetkemeyer (R-MO) Rep. Joe Wilson (R-SC) All of the above The answer is C: Statements by more ...
  2 weeks ago

• NY Times: Disclosure of congressional parrotry

  
  Knight Science Journalism Tracker — Authority: 143
  Rep. Joe Wilson of South Carolina (photo) likes biotech. “One of the reasons I have long supported the U.S. biotechnology industry is that it is a homegrown success story that has been an engine of job creation in this country.” Rep. Blaine Luetkemeyer of Missouri likes it, too. I needn’t bore you with her ...
  2 weeks ago

• Genentech Puts Words In The Mouths Of Politicians

  
  Pharmalot — Authority: 587
  If some Congressional statements about health care from Republicans and Democrats sounded similar, there was a good reason. Remarks by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, The New York Times reports. E-mail messages obtained by the paper ...
  2 weeks ago

• anyone who needs more proof

  
  ravings of a semi-sane madwoman — Authority: 491
  our country is run by big bid-nez is none too bright. its been there for you all along. heres a bit more THEIR words in OUR politicians mouths In House, Many Spoke With One Voice: Lobbyists’ By ROBERT PEAR WASHINGTON — In the official record of the historic House debate on overhauling health care, the ...
  2 weeks ago

• Republicans Who Let Corporate Lobbyists Write Their Speeches

  
  That's My Congress — Authority: 477
  These Republican members of Congress allowed lobbyists for a foreign organization to slip special statements into their official speeches.
  2 weeks ago

• Lawmakers delivered talking points written by drug company lobbyists

  
  Majikthise — Authority: 584
  Robert Pear of the New York Times exposes an old fashioned bipartisan scandal ; Genentech lobbyists wrote talking points for legislators and dozens of legislators used them: WASHINGTON — In the official record ofthe historic House debate on overhauling health care, the speeches ofmany lawmakers echo with ...
  2 weeks ago

• What a Roomful of Parrots Looks Like

  
  Emptywheel — Authority: 715
  As the NYT reported earlier today, Genentech/Roche wrote a Republican script and a Democratic script for its parrots to enter into the Congressional Record. Here’s what the Republican script looks like (I’m going to try to do the Democratic one next–but this is tedious stuff; and yes, Heath Shuler was working ...
  2 weeks ago

• Democrats Who Let Lobbyists Put Words In Their Mouths

  
  That's My Congress — Authority: 477
  The lobbyists who actually wrote the speeches for members of Congress were working for Genentech, a subsidiary of pharmaceutical corporation Roche, which has a substantial financial interest in blocking health care reform legislation.
  2 weeks ago

Comments about genentech